Mereo BioPharma Stock Price - MREO

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Mereo BioPharma Group PLC MREO NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.16 -9.04% 1.61 1.76 1.53 1.76 1.77 09:56:35
Bid Price Ask Price Spread Spread % News
1.65 1.76 0.11 6.25% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
73 16,787 $ 1.71 $ 28,671 466,015 1.00 - 6.5659
Last Trade Time Type Quantity Stock Price Currency
09:52:00 97 $ 1.65 USD

Mereo BioPharma Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 31.54M 19.59M $ -32.03M -2.87 - 19.59M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Mereo BioPharma News

Date Time Source News Article
1/14/202007:00GlobeNewswire Inc.Mereo BioPharma Announces Additional Positive Data from..
1/13/202008:26Edgar (US Regulatory)Report of Foreign Issuer (6-k)
1/13/202007:00GlobeNewswire Inc.Mereo BioPharma and Oncologie Enter into Global Licensing..
1/13/202007:00PR Newswire (US)Mereo BioPharma and Oncologie Enter into Global Licensing..
11/22/201909:30Edgar (US Regulatory)Report of Foreign Issuer (6-k)
11/11/201906:30GlobeNewswire Inc.Mereo BioPharma’s Setrusumab Demonstrates Dose-Dependent..
10/07/201912:23Edgar (US Regulatory)Report of Foreign Issuer (6-k)

Latest MREO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MREO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.152.151.401.77123,935-0.54-25.12%
1 Month3.053.401.402.33207,160-1.44-47.21%
3 Months3.143.741.002.49251,569-1.53-48.73%
6 Months2.654.2691.002.55118,850-1.04-39.25%
1 Year6.556.56591.002.6789,549-4.94-75.42%
3 Years6.556.56591.002.6789,549-4.94-75.42%
5 Years6.556.56591.002.6789,549-4.94-75.42%

Mereo BioPharma Description

Mereo BioPharma Group PLC is a multi-asset biopharmaceutical company. It is focused on the acquisition, development, and commercialization of innovative therapeutics to improve outcomes for patients with rare and specialty diseases. The company portfolio consists of clinical-stage product candidates that include BPS-804 (setrusumab), AZD-9668 (alvelestat), BGS-649 (leflutrozole), OMP-313M32 (etigilimab), OMP-305B83 (navicixizumab) and BCT-197 (acumapimod).
Your Recent History
NASDAQ
MREO
Mereo BioP..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200129 15:13:51